Angelalign Technology（77D）株式概要投資持株会社であるエンジェライン・テクノロジー社は、中華人民共和国および国際的なクリアアライナー治療ソリューションの研究、設計、製造、販売を行っています。 詳細77D ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長4/6過去の実績4/6財務の健全性6/6配当金3/6報酬収益は年間26.3%増加すると予測されています 過去1年間で収益は134.7%増加しました アナリストらは、株価が34.2%上昇するだろうとほぼ一致している。 リスク分析8.52%の配当はフリーキャッシュフローで十分にカバーされていない German市場と比較した過去 3 か月間の株価の変動過去3か月間に大規模なインサイダー売却が発生 すべてのリスクチェックを見る77D Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€7.3537.6% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0770m2016201920222025202620282031Revenue US$769.7mEarnings US$59.1mAdvancedSet Fair ValueView all narrativesAngelalign Technology Inc. 競合他社Eckert & ZieglerSymbol: XTRA:EUZMarket cap: €971.8mDrägerwerk KGaASymbol: XTRA:DRW3Market cap: €1.4bCarl Zeiss MeditecSymbol: XTRA:AFXMarket cap: €2.2bOttobock SE KGaASymbol: XTRA:OBCKMarket cap: €3.2b価格と性能株価の高値、安値、推移の概要Angelalign Technology過去の株価現在の株価HK$7.3552週高値HK$10.1052週安値HK$5.45ベータ1.191ヶ月の変化-17.88%3ヶ月変化-1.34%1年変化23.53%3年間の変化n/a5年間の変化n/aIPOからの変化12.21%最新ニュースNew Risk • Jun 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (257% cash payout ratio). Share price has been volatile over the past 3 months (8.5% average weekly change). Significant insider selling over the past 3 months (€18m sold).Declared Dividend • May 20Final dividend of HK$5.47 announcedShareholders will receive a dividend of HK$5.47. Ex-date: 21st May 2026 Payment date: 8th June 2026 Dividend yield will be 63%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but not covered by cash flows (257% cash payout ratio). The dividend has increased by an average of 106% per year over the past 3 years. However, payments have been volatile during that time. EPS is expected to grow by 105% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 14Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement ClaimAngelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded.お知らせ • Mar 29Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026.お知らせ • Mar 28+ 1 more updateAngelalign Technology Inc. announces Annual dividend, payable on June 08, 2026Angelalign Technology Inc. announced Annual dividend of HKD 0.4800 per share payable on June 08, 2026, ex-date on May 21, 2026 and record date on May 22, 2026.お知らせ • Feb 25Angelalign Technology Inc. to Report Fiscal Year 2025 Results on Mar 27, 2026Angelalign Technology Inc. announced that they will report fiscal year 2025 results on Mar 27, 2026最新情報をもっと見るRecent updatesNew Risk • Jun 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (257% cash payout ratio). Share price has been volatile over the past 3 months (8.5% average weekly change). Significant insider selling over the past 3 months (€18m sold).Declared Dividend • May 20Final dividend of HK$5.47 announcedShareholders will receive a dividend of HK$5.47. Ex-date: 21st May 2026 Payment date: 8th June 2026 Dividend yield will be 63%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but not covered by cash flows (257% cash payout ratio). The dividend has increased by an average of 106% per year over the past 3 years. However, payments have been volatile during that time. EPS is expected to grow by 105% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 14Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement ClaimAngelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded.お知らせ • Mar 29Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026.お知らせ • Mar 28+ 1 more updateAngelalign Technology Inc. announces Annual dividend, payable on June 08, 2026Angelalign Technology Inc. announced Annual dividend of HKD 0.4800 per share payable on June 08, 2026, ex-date on May 21, 2026 and record date on May 22, 2026.お知らせ • Feb 25Angelalign Technology Inc. to Report Fiscal Year 2025 Results on Mar 27, 2026Angelalign Technology Inc. announced that they will report fiscal year 2025 results on Mar 27, 2026お知らせ • Feb 13Align Technology Inc. Announces Preliminary European Court Ruling on Certain Software Features Will Have Minimal Impact on UsersAngelalign Technology Inc. said a ruling by the Unified Patent Court of Dusseldorf, Germany that it preliminarily cease its use of certain software functions that automatically update treatment plans would have minimal impact on the orthodontists and patients who use its clear aligner products. The ruling applies to certain European countries and excludes Spain, Switzerland, United Kingdom and Ireland. Angel will launch iPlan for applicable European users, which is an upgrade feature that has the same reliability and more flexibility for users. Angel denied that the Live Now feature in its iOrtho treatment planning software infringes any valid patents of Align Technology Inc. (ALGN). Angel has already filed an opposition against the patent with the European Patent Office (EPO), asserting that the claimed invention is neither novel nor inventive over the prior art, and is seeking its permanent invalidation. Angel is confident it will overcome the first- instance, non-final and preliminary injunction issued by the Dusseldorf court. For many years, Angel has focused on developing innovative solutions in the clear-aligner segment. Among its cutting-edge products are the award-winning angelButton, the angelHook, the A6 mandibular advancement system (now celebrating its ten-year anniversary), the angel KiD system, and the Intelligent Root System. The company is committed to bringing fair and healthy competition to the marketplace to benefit doctors and their patients.お知らせ • Sep 25Angelalign Technologies Remains Confident in Light of Its Competitor's New Complaint and Diversion TacticAngelalign Technology Inc. remained confident in its position in light of the fact that industry behemoth Align Technology Inc. (ALGN) has filed another meritless case against Angel, this time with the U.S. International Trade Commission. This is the latest in a barrage of lawsuits launched by Align. Angel promises an effective defense and is confident that it will prevail. The company has innovated and operated for over 20 years with a strong reputation and track record of respecting intellectual property. Angel serves doctors and patients in 60 countries and regularly receives industry-leading satisfaction ratings. Angel has proudly led the clear-aligner field in innovation for many years while also recognizing Align's founding role in creating the industry years ago. Some examples of Angel's cutting-edge products are: The angelButton™ and the angelHook™, which allow orthodontists to manage forces effectively when using elastics. The A6 mandibular advancement system, which implements the twin-block orthodontic concept for doctors to move the mandible. AngelKid, a leading system to treat mixed dentition for young patients. Intelligent Root System, which allows orthodontists to use 3D imaging for treatment planning.お知らせ • Aug 19Align Technology Initiates Patent Infringement Ligitation Against Angelalign TechnologyAlign Technology Inc. announced the filing of patent infringement lawsuits against Angelalign Technology Inc. (Angel). The lawsuits allege that Angel’s products and associated software infringe Align patents, which encompass innovations such as multilayer aligner materials, cutting-edge treatment planning, and advanced aligner features. These legal actions have been initiated in the United States, Europe and China, jurisdictions where Align has made significant investments in innovation, aligner fabrication and treatment planning. Align seeks both injunctive relief and monetary damages through these intellectual property enforcement efforts.お知らせ • Aug 09Angelalign Technology Inc. to Report First Half, 2025 Results on Aug 25, 2025Angelalign Technology Inc. announced that they will report first half, 2025 results on Aug 25, 2025お知らせ • Mar 20Angelalign Technology Inc. Proposes Special Final Dividend for the Year Ended 31 December 2024, Payable on 20 June 2025Angelalign Technology Inc. proposed special final dividend of HKD 0.38 per share for the year ended 31 December 2024. Date of shareholders' approval is 23 May 2025. Ex-dividend date is 27 May 2025. Record date is 2 June 2025. Payment date is 20 June 2025.お知らせ • Mar 05Angelalign Technology Inc. to Report Fiscal Year 2024 Results on Mar 20, 2025Angelalign Technology Inc. announced that they will report fiscal year 2024 results on Mar 20, 2025株主還元77DDE Medical EquipmentDE 市場7D-1.3%-1.2%0.6%1Y23.5%-27.5%3.8%株主還元を見る業界別リターン: 77D過去 1 年間で-27.5 % の収益を上げたGerman Medical Equipment業界を上回りました。リターン対市場: 77D過去 1 年間で3.8 % の収益を上げたGerman市場を上回りました。価格変動Is 77D's price volatile compared to industry and market?77D volatility77D Average Weekly Movement8.5%Medical Equipment Industry Average Movement6.2%Market Average Movement5.9%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.8%安定した株価: 77Dの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 77Dの weekly volatility ( 8% ) は過去 1 年間安定していますが、依然としてGermanの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20034,312Fox Huwww.angelalign.com投資持株会社であるAngelalign Technology Inc.は、中華人民共和国および国際的なクリアアライナー治療ソリューションの研究、設計、製造、販売を行っています。同社の製品には、時間をかけて患者の歯を適切な位置に移動させる、カスタムメイドの取り外し可能な透明矯正アライナー「エンジェルアライナー・プロ」などがある。また、歯科クリニックを通じて矯正歯科や審美歯科、その他の歯科サービスを提供するほか、口腔内スキャナーの販売も行っている。エンジェライン・テクノロジー社は2003年に設立され、中国の上海に本社を置いている。アンジェライン・テクノロジー社はケアキャピタル・オーソテック社の子会社である。もっと見るAngelalign Technology Inc. 基礎のまとめAngelalign Technology の収益と売上を時価総額と比較するとどうか。77D 基礎統計学時価総額€1.32b収益（TTM）€24.74m売上高(TTM)€322.18m53.4xPER（株価収益率4.1xP/Sレシオ77D は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計77D 損益計算書（TTM）収益US$370.28m売上原価US$137.39m売上総利益US$232.89mその他の費用US$204.45m収益US$28.44m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）0.17グロス・マージン62.90%純利益率7.68%有利子負債／自己資本比率0.5%77D の長期的なパフォーマンスは？過去の実績と比較を見る配当金8.5%現在の配当利回り37%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/17 20:36終値2026/06/17 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Angelalign Technology Inc. 10 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Bo LiBofA Global ResearchYanyin ZhuChina International Capital Corporation LimitedMujun ShenCitic Securities Co., Ltd.8 その他のアナリストを表示
New Risk • Jun 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (257% cash payout ratio). Share price has been volatile over the past 3 months (8.5% average weekly change). Significant insider selling over the past 3 months (€18m sold).
Declared Dividend • May 20Final dividend of HK$5.47 announcedShareholders will receive a dividend of HK$5.47. Ex-date: 21st May 2026 Payment date: 8th June 2026 Dividend yield will be 63%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but not covered by cash flows (257% cash payout ratio). The dividend has increased by an average of 106% per year over the past 3 years. However, payments have been volatile during that time. EPS is expected to grow by 105% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 14Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement ClaimAngelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded.
お知らせ • Mar 29Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026.
お知らせ • Mar 28+ 1 more updateAngelalign Technology Inc. announces Annual dividend, payable on June 08, 2026Angelalign Technology Inc. announced Annual dividend of HKD 0.4800 per share payable on June 08, 2026, ex-date on May 21, 2026 and record date on May 22, 2026.
お知らせ • Feb 25Angelalign Technology Inc. to Report Fiscal Year 2025 Results on Mar 27, 2026Angelalign Technology Inc. announced that they will report fiscal year 2025 results on Mar 27, 2026
New Risk • Jun 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (257% cash payout ratio). Share price has been volatile over the past 3 months (8.5% average weekly change). Significant insider selling over the past 3 months (€18m sold).
Declared Dividend • May 20Final dividend of HK$5.47 announcedShareholders will receive a dividend of HK$5.47. Ex-date: 21st May 2026 Payment date: 8th June 2026 Dividend yield will be 63%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but not covered by cash flows (257% cash payout ratio). The dividend has increased by an average of 106% per year over the past 3 years. However, payments have been volatile during that time. EPS is expected to grow by 105% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 14Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement ClaimAngelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded.
お知らせ • Mar 29Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026.
お知らせ • Mar 28+ 1 more updateAngelalign Technology Inc. announces Annual dividend, payable on June 08, 2026Angelalign Technology Inc. announced Annual dividend of HKD 0.4800 per share payable on June 08, 2026, ex-date on May 21, 2026 and record date on May 22, 2026.
お知らせ • Feb 25Angelalign Technology Inc. to Report Fiscal Year 2025 Results on Mar 27, 2026Angelalign Technology Inc. announced that they will report fiscal year 2025 results on Mar 27, 2026
お知らせ • Feb 13Align Technology Inc. Announces Preliminary European Court Ruling on Certain Software Features Will Have Minimal Impact on UsersAngelalign Technology Inc. said a ruling by the Unified Patent Court of Dusseldorf, Germany that it preliminarily cease its use of certain software functions that automatically update treatment plans would have minimal impact on the orthodontists and patients who use its clear aligner products. The ruling applies to certain European countries and excludes Spain, Switzerland, United Kingdom and Ireland. Angel will launch iPlan for applicable European users, which is an upgrade feature that has the same reliability and more flexibility for users. Angel denied that the Live Now feature in its iOrtho treatment planning software infringes any valid patents of Align Technology Inc. (ALGN). Angel has already filed an opposition against the patent with the European Patent Office (EPO), asserting that the claimed invention is neither novel nor inventive over the prior art, and is seeking its permanent invalidation. Angel is confident it will overcome the first- instance, non-final and preliminary injunction issued by the Dusseldorf court. For many years, Angel has focused on developing innovative solutions in the clear-aligner segment. Among its cutting-edge products are the award-winning angelButton, the angelHook, the A6 mandibular advancement system (now celebrating its ten-year anniversary), the angel KiD system, and the Intelligent Root System. The company is committed to bringing fair and healthy competition to the marketplace to benefit doctors and their patients.
お知らせ • Sep 25Angelalign Technologies Remains Confident in Light of Its Competitor's New Complaint and Diversion TacticAngelalign Technology Inc. remained confident in its position in light of the fact that industry behemoth Align Technology Inc. (ALGN) has filed another meritless case against Angel, this time with the U.S. International Trade Commission. This is the latest in a barrage of lawsuits launched by Align. Angel promises an effective defense and is confident that it will prevail. The company has innovated and operated for over 20 years with a strong reputation and track record of respecting intellectual property. Angel serves doctors and patients in 60 countries and regularly receives industry-leading satisfaction ratings. Angel has proudly led the clear-aligner field in innovation for many years while also recognizing Align's founding role in creating the industry years ago. Some examples of Angel's cutting-edge products are: The angelButton™ and the angelHook™, which allow orthodontists to manage forces effectively when using elastics. The A6 mandibular advancement system, which implements the twin-block orthodontic concept for doctors to move the mandible. AngelKid, a leading system to treat mixed dentition for young patients. Intelligent Root System, which allows orthodontists to use 3D imaging for treatment planning.
お知らせ • Aug 19Align Technology Initiates Patent Infringement Ligitation Against Angelalign TechnologyAlign Technology Inc. announced the filing of patent infringement lawsuits against Angelalign Technology Inc. (Angel). The lawsuits allege that Angel’s products and associated software infringe Align patents, which encompass innovations such as multilayer aligner materials, cutting-edge treatment planning, and advanced aligner features. These legal actions have been initiated in the United States, Europe and China, jurisdictions where Align has made significant investments in innovation, aligner fabrication and treatment planning. Align seeks both injunctive relief and monetary damages through these intellectual property enforcement efforts.
お知らせ • Aug 09Angelalign Technology Inc. to Report First Half, 2025 Results on Aug 25, 2025Angelalign Technology Inc. announced that they will report first half, 2025 results on Aug 25, 2025
お知らせ • Mar 20Angelalign Technology Inc. Proposes Special Final Dividend for the Year Ended 31 December 2024, Payable on 20 June 2025Angelalign Technology Inc. proposed special final dividend of HKD 0.38 per share for the year ended 31 December 2024. Date of shareholders' approval is 23 May 2025. Ex-dividend date is 27 May 2025. Record date is 2 June 2025. Payment date is 20 June 2025.
お知らせ • Mar 05Angelalign Technology Inc. to Report Fiscal Year 2024 Results on Mar 20, 2025Angelalign Technology Inc. announced that they will report fiscal year 2024 results on Mar 20, 2025
